240 related articles for article (PubMed ID: 38000306)
21. Targeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody Responses.
Cuenca M; Romero X; Sintes J; Terhorst C; Engel P
J Immunol; 2016 Jan; 196(2):726-37. PubMed ID: 26667173
[TBL] [Abstract][Full Text] [Related]
22. Loss of tolerance of anti-dsDNA B cells in mice overexpressing CD19.
Taylor DK; Ito E; Thorn M; Sundar K; Tedder T; Spatz LA
Mol Immunol; 2006 Apr; 43(11):1776-90. PubMed ID: 16430962
[TBL] [Abstract][Full Text] [Related]
23. Enhanced IgA class switching in marginal zone and B1 B cells relative to follicular/B2 B cells.
Kaminski DA; Stavnezer J
J Immunol; 2006 Nov; 177(9):6025-9. PubMed ID: 17056527
[TBL] [Abstract][Full Text] [Related]
24. Intraperitoneal metastasis of ovarian cancer: new insights on resident macrophages in the peritoneal cavity.
Miyamoto T; Murphy B; Zhang N
Front Immunol; 2023; 14():1104694. PubMed ID: 37180125
[TBL] [Abstract][Full Text] [Related]
25. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms.
Amano M; Baumgarth N; Dick MD; Brossay L; Kronenberg M; Herzenberg LA; Strober S
J Immunol; 1998 Aug; 161(4):1710-7. PubMed ID: 9712035
[TBL] [Abstract][Full Text] [Related]
26. Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.
Yoshida M; Taguchi A; Kawana K; Adachi K; Kawata A; Ogishima J; Nakamura H; Fujimoto A; Sato M; Inoue T; Nishida H; Furuya H; Tomio K; Arimoto T; Koga K; Wada-Hiraike O; Oda K; Nagamatsu T; Kiyono T; Osuga Y; Fujii T
PLoS One; 2016; 11(8):e0160330. PubMed ID: 27483433
[TBL] [Abstract][Full Text] [Related]
27. Cutting edge: Krűppel-like factor 2 is required for phenotypic maintenance but not development of B1 B cells.
Hart GT; Peery SL; Hamilton SE; Jameson SC
J Immunol; 2012 Oct; 189(7):3293-7. PubMed ID: 22942434
[TBL] [Abstract][Full Text] [Related]
28. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells.
Xue L; Morris SW; Orihuela C; Tuomanen E; Cui X; Wen R; Wang D
Nat Immunol; 2003 Sep; 4(9):857-65. PubMed ID: 12910267
[TBL] [Abstract][Full Text] [Related]
29. Redundant role for Zap70 in B cell development and activation.
Fallah-Arani F; Schweighoffer E; Vanes L; Tybulewicz VL
Eur J Immunol; 2008 Jun; 38(6):1721-33. PubMed ID: 18465772
[TBL] [Abstract][Full Text] [Related]
30. Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages.
Rei M; Gonçalves-Sousa N; Lança T; Thompson RG; Mensurado S; Balkwill FR; Kulbe H; Pennington DJ; Silva-Santos B
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):E3562-70. PubMed ID: 25114209
[TBL] [Abstract][Full Text] [Related]
31. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses.
Balázs M; Martin F; Zhou T; Kearney J
Immunity; 2002 Sep; 17(3):341-52. PubMed ID: 12354386
[TBL] [Abstract][Full Text] [Related]
32. Role of B1 and B2 lymphocytes in placental ischemia-induced hypertension.
Laule CF; Odean EJ; Wing CR; Root KM; Towner KJ; Hamm CM; Gilbert JS; Fleming SD; Regal JF
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H732-H742. PubMed ID: 31397167
[TBL] [Abstract][Full Text] [Related]
33. Staphylococcal protein a deletes B-1a and marginal zone B lymphocytes expressing human immunoglobulins: an immune evasion mechanism.
Viau M; Longo NS; Lipsky PE; Zouali M
J Immunol; 2005 Dec; 175(11):7719-27. PubMed ID: 16301682
[TBL] [Abstract][Full Text] [Related]
34. Critical role of IL-25-ILC2-IL-5 axis in the production of anti-Francisella LPS IgM by B1 B cells.
Barbosa CHD; Lantier L; Reynolds J; Wang J; Re F
PLoS Pathog; 2021 Aug; 17(8):e1009905. PubMed ID: 34449811
[TBL] [Abstract][Full Text] [Related]
35. B cells are crucial for both development and maintenance of the splenic marginal zone.
Nolte MA; Arens R; Kraus M; van Oers MH; Kraal G; van Lier RA; Mebius RE
J Immunol; 2004 Mar; 172(6):3620-7. PubMed ID: 15004164
[TBL] [Abstract][Full Text] [Related]
36. The peritoneal micromilieu commits B cells to home to body cavities and the small intestine.
Berberich S; Förster R; Pabst O
Blood; 2007 Jun; 109(11):4627-34. PubMed ID: 17289810
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine-1-Phosphate Receptor Type 4 (S1P
Riese J; Gromann A; Lührs F; Kleinwort A; Schulze T
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801658
[TBL] [Abstract][Full Text] [Related]
38. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
39. Depletion of regulatory T lymphocytes reverses the imbalance between pro- and anti-tumor immunities via enhancing antigen-specific T cell immune responses.
Chen YL; Chang MC; Chen CA; Lin HW; Cheng WF; Chien CL
PLoS One; 2012; 7(10):e47190. PubMed ID: 23082146
[TBL] [Abstract][Full Text] [Related]
40. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells.
Kawahara T; Ohdan H; Zhao G; Yang YG; Sykes M
J Immunol; 2003 Nov; 171(10):5406-14. PubMed ID: 14607944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
